Top Markets
#1 Black Phoenix Black Phoenix +361.13%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.60%
#5 Akedo Akedo +45.03%
#6 BasedHype BasedHype +32.41%
#7 Acurast Acurast +26.37%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.69%
#10 Playnance Playnance +18.61%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
株式のランク #41147
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
株価
$0.04082105
最終同期: 2024-08-12
時価総額
$39.09K
変化（1日）
-19.83%
変化（1年）
0.00%
国
GB
取引 Destiny Pharma plc (DEST)

カテゴリー

Healthcare
Destiny Pharma plc（DEST）のP/S比率
August 2026 時点のP/S比率 TTM: 3.46
Destiny Pharma plc の最新の財務報告および株価によると、現在のP/S比率（TTM）は 3.46 です。2022 年末時点でのP/S比率は 243.09 でした。
Destiny Pharma plc の P/S 比率の履歴（2013 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
2026 (TTM) 3.46 -95.47%
2023 76.33 -68.60%
2022 243.09 -47.78%
2021 465.54 -81.29%
2020 2.49K 3,941.09%
2019 61.58 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 185.98%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 198.20%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 44.11%
BE